BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22610820)

  • 1. Pathogenesis of cholestatic itch: old questions, new answers, and future opportunities.
    Jones DE
    Hepatology; 2012 Oct; 56(4):1194-6. PubMed ID: 22610820
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
    Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
    Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanism of cholestatic pruritus.
    Oude Elferink RP; Kremer AE; Martens JJ; Beuers UH
    Dig Dis; 2011; 29(1):66-71. PubMed ID: 21691108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroendocrine cells are a potential source of serum autotaxin in men.
    Bolier R; Tolenaars D; Kremer AE; Saris J; Parés A; Verheij J; Bosma PJ; Beuers U; Oude Elferink RPJ
    Biochim Biophys Acta; 2016 Apr; 1862(4):696-704. PubMed ID: 26775031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.
    Wunsch E; Krawczyk M; Milkiewicz M; Trottier J; Barbier O; Neurath MF; Lammert F; Kremer AE; Milkiewicz P
    Sci Rep; 2016 Aug; 6():30847. PubMed ID: 27506882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
    Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
    Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum autotaxin levels correlate with pruritus in patients with atopic dermatitis.
    Nakao M; Sugaya M; Suga H; Kawaguchi M; Morimura S; Kai H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2014 Jun; 134(6):1745-1747. PubMed ID: 24441098
    [No Abstract]   [Full Text] [Related]  

  • 9. Mediators of pruritus during cholestasis.
    Oude Elferink RP; Kremer AE; Beuers U
    Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys.
    Bergasa NV; Thomas DA; Vergalla J; Turner ML; Jones EA
    Life Sci; 1993; 53(16):1253-7. PubMed ID: 8412484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on Haemodialysis.
    Mettang T; Kunzmann K; Roth HJ; Weisshaar E
    Acta Derm Venereol; 2017 Mar; 97(3):381-382. PubMed ID: 27671605
    [No Abstract]   [Full Text] [Related]  

  • 13. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy.
    Kremer AE; Bolier R; Dixon PH; Geenes V; Chambers J; Tolenaars D; Ris-Stalpers C; Kaess BM; Rust C; van der Post JA; Williamson C; Beuers U; Oude Elferink RP
    J Hepatol; 2015 Apr; 62(4):897-904. PubMed ID: 25450205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of pruritus in cholestasis.
    Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
    Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol and cholestatic pruritus.
    Borgeat A; Wilder-Smith O; Mentha G; Huber O
    Am J Gastroenterol; 1992 May; 87(5):672-4. PubMed ID: 1595661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Out-patient' albumin dialysis for cholestatic patients with intractable pruritus.
    Leckie P; Tritto G; Mookerjee R; Davies N; Jones D; Jalan R
    Aliment Pharmacol Ther; 2012 Mar; 35(6):696-704. PubMed ID: 22260552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin as treatment for pruritus in malignant cholestasis.
    Price TJ; Patterson WK; Olver IN
    Support Care Cancer; 1998 Nov; 6(6):533-5. PubMed ID: 9833303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of pruritus in patients with cholestatic liver disease].
    Kremer AE; Kraus MR
    MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
    [No Abstract]   [Full Text] [Related]  

  • 19. Nasobiliary drainage in acute cholestatic hepatitis with pruritus.
    Singh V; Bhalla A; Sharma N; Dheerendra PC; Agarwal R; Mahi SK
    Dig Liver Dis; 2009 Jun; 41(6):442-5. PubMed ID: 18657488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pruritus in liver disease. Pathogenesis and treatment].
    Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
    Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.